Recent Stories
- Unborn babies 'practise' facial expressions in the womb
- Lancaster leads the way in cyber security bursary scheme
- Physicists gain insight into the UK's biggest killer
- Engineering students make finals of national start-up business competition
- Social media plagued by privacy problems, say researchers
- Lancaster Environment Centre conducts roadside pollution research for BBC
- Lancaster set to receive funding boost to stimulate UK's economy
- Billion-year-old water could hold clues to life on Earth and Mars
- How do we find out about cyber criminals?
- First, carbon footprints... now you can calculate your 'nitrogen footprint'
Award for Lancaster graduate's £3m biotech consultancy firm
Story supplied by LU Press Office
from left: Gillian Gregory and Sarah Fryer of Gregory Fryer Associates Ltd with their award for Professional Service Provider of the Year
A Lancaster biology graduate has founded an award-winning pharmaceutical consultancy with a turnover of over £3m and staff in both the UK and US.
Sarah Fryer and her business partner Gillian Gregory launched Gregory Fryer Associates Ltd (GFA) in 2003 as a consultancy company for the biotechnology industry. It provides expert support in the development of gene therapies and stem cell therapies, often in areas of unmet medical need like multiple sclerosis.
By 2010 the company had expanded to 30 people, conducting clinical trials in Europe and the USA and working with companies from all over the world.
The company, based in Ely in Cambridgeshire, was named Professional Service Provider of the Year 2010 at the Genesis Biotechnology Conference in London this December.
Sarah Fryer said: "This award is a marvellous achievement for the entire team at GFA, and an acknowledgement by our industry peers that GFA is providing a useful contribution to the development of new therapies."
She graduated from Lancaster University in Biological Sciences in 1984 and said her tutor helped steer her career in the right direction.
"After a first year of getting to know everyone, the campus college bar-crawls and the nights at the Sugarhouse in town, it was down to hard work and some great field trips up to the Lakes. Not entirely sure about where my career was heading, I am forever indebted to my third year tutor Dr Keith Jones who spotted that there were often jobs advertised in the field of toxicology. "
After an MSc in Toxicology, she worked in clinical research, monitoring clinical trials with new drugs, and eventually became the head of the UK office of a European clinical research organisation.
This leadership role gave her the confidence to set up her own company and the firm is now so successful that it has been bought out by an international research organisation which has retained both Sarah Fryer and Gillian Gregory as company directors.
Thu 03 February 2011
Associated Links
- Biology at Lancaster - information on studying Biological Sciences at Lancaster University
Latest News
Unborn babies 'practise' facial expressions in the womb
Researchers from Durham and Lancaster Universities suggest that a foetus's ability to show a "pain" facial expression is a developmental process which could potentially give doctors another index of the health of a foetus.
Story supplied by LU Press Office
Mon 17 June 2013
Lancaster leads the way in cyber security bursary scheme
Lancaster is one of four UK universities selected to take part in an 'industry first' sponsorship initiative encouraging students to take up Masters-level cyber security degrees.
Story supplied by LU Press Office
Mon 10 June 2013
Physicists gain insight into the UK's biggest killer
Cardiovascular disease is the leading cause of death in the UK, accounting for a third of all fatalities through illnesses such as stroke and heart disease.
Story supplied by LU Press Office
Wed 29 May 2013
Engineering students make finals of national start-up business competition
Engineering students Scott Nash, Daniel Richardson and Aaron Aboshio have won the northern heat of the Youth Entrepreneurs Scheme 'Engineering YES' competition for their spin-out renewable energy company Atlantis.
Thu 23 May 2013